Lone Star Bio
Filter News
Found 12,399 articles
-
SelenBio™️ Marks One Year Since Launch of FDA-Approved Dental Breakthrough
2/19/2019
New Year to Bring New Technologies for Thriving Company
-
Nova Medical Centers Hosts 2019 Leadership Conference in Houston
2/19/2019
On February 9, 2019 Nova Medical Centers, the nation's leading pure occupational medicine provider, held its Second Annual Leadership Conference in Houston, TX.
-
Genprex Appoints John N. Bonfiglio, PhD, to Board of Directors
2/19/2019
Experienced Biotech Executive Brings More Than 30 Years of Pharmaceutical and Biotechnology Experience to Genprex
-
WHO Plans to Develop Oversight Standards for Gene Editing Following Chinese Researcher’s Experiment
2/15/2019
Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action. -
February 15 Research Roundup: Rare Pediatric Cancer, Hibernating Hamsters, Prostate Cancer and More
2/15/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Forbius Announces a Clinical Trial Collaboration with the Myeloproliferative Neoplasm Research Consortium to Evaluate AVID200, a Novel TGF-beta Inhibitor, in Myelofibrosis
2/14/2019
MPN-RC sponsored, NIH-supported Phase 1/2 trial in myelofibrosis to commence imminently
-
Proxima Clinical Research Launches New Campaign Entitled "We Love Startups" along with an Expert HelpDesk
2/14/2019
A new chat feature that connects you directly to clinical and regulatory specialists
-
ESO and Prehospital Care Research Forum at UCLA Partner for ESO Research Forum at Wave Conference
2/14/2019
Registration open for EMS professionals to join forces with clinical leaders, researchers and data analysts to undertake real-world projects aimed at improving community health and safety through the power of data
-
Lawmakers continue to hear concerns over drug prices, as well as proposals to fix the issue.
-
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to treat patient in study to evaluate balloon ablation catheter for treating Atrial Fibrillation
2/13/2019
The study is designed to evaluate the safety and effectiveness of the catheter in treating intermittent atrial fibrillation (A Fib), the most common type of irregular heartbeat.
-
Corpus Christi Women's Clinic Joins Research Ready Network, Offers Clinical Research as Care Option to Patients
2/13/2019
As a result of this partnership, the practice will expand the treatment options it offers patients by supporting research studies conducted in its practice.
-
U.S. Renal Care to Be Acquired by Investor Group
2/13/2019
U.S. Renal Care will continue to operate under its current management team, who will remain significant investors in the company. Financial terms of the private transaction were not disclosed.
-
First reported by the San Antonio Business Journal, the company will cut about 265 employees, 200 from its Alamo City site and the rest from its Charlotte facility. The cuts are part of a restructuring and will be handled over time, rather than all in one fell swoop of pink slips.
-
Adeptus Health Appoints James Hopwood as its Chief Financial Officer
2/12/2019
Hopwood officially joined Adeptus on October 15, 2018.
-
Dr. Gregory A. Hosler Elected President of Texas Society of Pathologists
2/12/2019
Gregory A. Hosler, M.D., Ph.D., FCAP, ProPath’s Director of Dermatopathology and Fellowship Program Director, was recently elected President of the Texas Society of Pathologists and sworn in during the 98th Annual Meeting in Bastrop, Texas.
-
Alexander (Sasha) Opotowsky, associate professor at Harvard Medical School and a cardiologist at Boston Children’s Hospital and Brigham and Women’s Hospital took time out to speak with BioSpace about advances in heart health, congenital heart disease (CHD), biopharma, and the Adult Congenital Hea...
-
SpinalCyte Announces New Canadian Patent
2/11/2019
The company received IND clearance from the FDA in November to continue clinical trials into its lead fibroblast cell therapy product, CybroCell, in the treatment of degenerative disc disease.
-
ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
2/11/2019
ESSA compounds have been selected for a poster presentation at the upcoming 2019 Genitourinary Cancers Symposium to be held February 14 – 16, 2019 at the Moscone Center in San Francisco, CA.
-
Report Shows Life Science Companies Continue to Be a Favorite Target of Securities Fraud Class Ac...
2/8/2019
Despite a decline over the past year of class-action lawsuits, life science companies remain a popular target for securities fraud litigation. -
BioSpace Movers and Shakers: Feb. 8
2/8/2019
In this week's edition of Movers and Shakers, biopharma companies tap executives to serve in various leadership roles.